Macular Degeneration Treatment Market Insights Highlighting Growth Opportunities Through 2030
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
From Its 2026 Market Size, What Value Is The Macular Degeneration Treatment Market Projected To Reach By 2030?
The macular degeneration treatment market size has seen rapid expansion in recent years. It is anticipated to increase from $12.38 billion in 2025 to $13.81 billion in 2026, progressing at a compound annual growth rate (CAGR) of 11.5%. This historical growth can be attributed to an aging global population, the heightened prevalence of age-related macular degeneration, the clinical efficacy of anti-vegf injections, enhancements in ophthalmic diagnostic capabilities, and wider access to specialized eye care services.
The macular degeneration treatment market size is anticipated to expand significantly over the next few years, reaching $20.74 billion by 2030, with a compound annual growth rate (CAGR) of 10.7%. This projected growth can be attributed to a globally increasing elderly population, greater investment in advanced retinal therapies, an intensified focus on early-stage AMD management, the expanding adoption of gene and regenerative therapies, and higher healthcare spending on vision care. Throughout this period, key trends will include a rising focus on early diagnosis and controlling disease progression, the growing adoption of anti-VEGF therapies, an increasing demand for long-term vision preservation treatments, the expansion of minimally invasive treatment options, and increased awareness of age-related eye disorders.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5799&type=smp
Which Drivers Are Supporting The Macular Degeneration Treatment Market Growth?
The rising prevalence of retinal disorders is anticipated to propel the expansion of the macular degeneration treatment market. These conditions affect vital eye tissue and disrupt how individuals process visual information, leading to vision that is either distorted or entirely absent. For instance, the American Academy of Ophthalmology estimates that by 2050, approximately 7.32 million people in the United States will have primary open-angle glaucoma, a broad term for a range of eye disorders, with the highest numbers projected for populations aged 70 to 79 years (32%), women (50%), and Hispanics (50%). The largest demographic group within this population is Hispanic men. Therefore, the increasing burden of retinal disorders is a significant driver for the growth of the macular degeneration treatment market.
How Is The Macular Degeneration Treatment Market Broken Down By Segment Categories?
The macular degeneration treatment market covered in this report is segmented –
1) By Stage of Disease: Early-Stage AMD, Intermediate AMD, Late-Stage AMD
2) By Route of Administration: Oral, Injectable, Other Routes of Administration
3) By End User: Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals
Subsegments:
1) By Early-Stage AMD: Nutritional Supplements, Lifestyle Modification Treatments
2) By Intermediate AMD: Regular Disease Monitoring and Imaging Surveillance, Risk-Factor Management and Lifestyle Modification
3) By Late-Stage AMD: Surgical Treatments, Advanced Anti-VEGF Therapies, Gene Therapy Options
Which Trends Are Expected To Impact The Macular Degeneration Treatment Market?
Companies operating within the macular degeneration treatment market are primarily concentrating on the development of biosimilars for age-related macular degeneration (AMD) to broaden the availability of efficacious therapies. Biosimilars are defined as biological medical products that share a high degree of similarity with an already approved reference product, lacking any clinically meaningful distinctions in terms of safety, purity, or potency. As an illustration, in May 2024, Biocon Biologics Ltd, an Indian entity, and Samsung Bioepis Co. Ltd, a South Korea-based firm, obtained FDA Approvals for Yesafili and Opuviz, two novel biosimilars. Both biosimilars function by inhibiting vascular endothelial growth factor (VEGF), which is responsible for the aberrant growth of blood vessels within the eye. This action serves to prevent vision loss linked with conditions such as AMD and diabetic retinopathy. The FDA’s approval included comparative studies that showed no significant differences in efficacy or safety for Yesafili and Opuviz when compared to Eylea. These studies involved meticulous assessments of the biosimilars’ pharmacokinetics and immunogenicity.
Which Players Are Present In The Macular Degeneration Treatment Market Space?
Major companies operating in the macular degeneration treatment market are F Hoffmann La Roche Ltd, Regeneron Pharmaceuticals Inc, Novartis AG, Bayer AG, Allergan Inc, Bausch Health Companies Inc, Santen Pharmaceutical Co Ltd, Alimera Sciences Inc, Apellis Pharmaceuticals Inc, Iveric Bio Inc, Aerie Pharmaceuticals Inc, Kodiak Sciences Inc, Neurotech Pharmaceuticals Inc, Regenxbio Inc, Adverum Biotechnologies Inc, Applied Genetic Technologies Corp, 4D Molecular Therapeutics Inc, GenSight Biologics SA, Nanoscope Therapeutics Inc, Annexon Inc, Ocular Therapeutix Inc, Graybug Vision Inc
Get The Full Macular Degeneration Treatment Market Report:
Which Region Is The Top Contributor To The Macular Degeneration Treatment Market By Share?
North America was the largest region in the macular degeneration treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the macular degeneration treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Macular Degeneration Treatment Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Macular Degeneration Treatment Market 2026, By The Business Research Company
Antibiotics Market Report 2026
https://www.thebusinessresearchcompany.com/report/antibiotics-global-market-report
Peptide Antibiotics Market Report
https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report
Veterinary Antibiotics Market Report
https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
